| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.56M | 72.16M | 401.71M | 32.00M | 34.64M | 28.35M |
| Gross Profit | -300.07M | -266.34M | 225.56M | 4.42M | 20.31M | 7.25M |
| EBITDA | -18.26M | -186.00K | 87.27M | -9.26M | 170.00K | 8.47M |
| Net Income | -62.41M | -51.43M | 3.87M | -24.79M | -3.96M | -541.00K |
Balance Sheet | ||||||
| Total Assets | 0.00 | 1.72B | 1.65B | 1.24B | 1.07B | 904.20M |
| Cash, Cash Equivalents and Short-Term Investments | 306.05M | 383.01M | 141.58M | 43.95M | 13.46M | 15.02M |
| Total Debt | 0.00 | 230.63M | 268.54M | 131.67M | 149.41M | 10.00M |
| Total Liabilities | -352.07M | 1.36B | 1.14B | 417.04M | 224.45M | 55.16M |
| Stockholders Equity | 352.07M | 346.84M | 507.00M | 820.17M | 845.00M | 848.90M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 343.08M | -282.94M | 118.65M | -20.16M | -21.54M |
| Operating Cash Flow | 0.00 | 558.96M | -251.52M | 185.20M | -20.07M | -21.54M |
| Investing Cash Flow | 0.00 | -269.93M | 133.87M | -121.98M | -120.10M | 38.00K |
| Financing Cash Flow | 0.00 | -31.12M | 112.25M | -32.73M | 138.62M | -1.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
55 Neutral | ₹197.25M | ― | ― | 1.70% | -93.62% | -115.49% | |
54 Neutral | ₹443.71M | 12.03 | ― | ― | 797.65% | ― | |
49 Neutral | ₹309.65M | -15.86 | ― | ― | -12.64% | -390.34% | |
48 Neutral | ₹214.56M | -5.26 | ― | ― | -62.38% | 21.41% | |
45 Neutral | ₹845.78M | -14.99 | ― | ― | -29.62% | -308.12% | |
44 Neutral | ₹227.59M | 390.23 | ― | ― | ― | ― |
Onelife Capital Advisors Limited has announced the closure of its trading window for all designated persons from 1 January 2026 until 48 hours after the declaration of its unaudited financial results for the quarter ended 31 December 2025, in compliance with SEBI’s Prohibition of Insider Trading Regulations, 2015. The move is a standard governance measure aimed at preventing insider trading ahead of the upcoming quarterly results, and the company has stated that the board meeting date to approve the standalone and consolidated unaudited financial results will be communicated in due course.
Onelife Capital Advisors Limited, a financial services and capital markets advisory firm listed on BSE and NSE, operates within India’s securities markets and caters to investors through its capital-raising and related advisory activities. The company has informed the exchanges that its Rights Issue Committee meeting, previously scheduled for 23 December 2025 after an earlier rescheduling, has been cancelled because in-principle approvals from BSE and NSE for the proposed rights issue are still pending; the company plans to reconvene the committee meeting once the requisite approvals are received and will issue a fresh exchange intimation at that time, signalling a procedural delay in its capital-raising plans but not an abandonment of the rights issue.
Onelife Capital Advisors Limited has announced the approval of a rights issue to raise up to Rs 30 Crores through the issuance of equity shares to existing shareholders, subject to regulatory approvals. Additionally, the company plans to acquire equity shares of Family Care Hospitals Limited from a related party, and has constituted a Rights Issue Committee to oversee the process, indicating strategic moves to strengthen its financial position and expand its market presence.